Sangani Hospitals
- Market cap
- ₹ 82 Cr.
- P/E
- 28.9x
- P/B
- 2.01x
- 52-week range
- 37 – 70.35
- ROE
- 8%
- ROCE
- 17%
- Dividend yield
- 0%
- Debt / equity
- 0.04
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE SME
About
Sangani Hospitals Limited is an India-based company, which is a multi-specialty healthcare provider operating in Keshod and Veraval regions of Gujarat. The Company’s services include specialty services in hospitals, and it also operates a pathology laboratory and medical stores. The Company operates approximately two hospitals, which are Sangani Hospital at Keshod, Junagadh, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. Sangani Hospital consists of approximately 36 bed multi-specialty hospital with primary, secondary, and tertiary care facilities. Sangani Super Speciality Hospital consists of approximately 32 bed multi-specialty hospital with a significant focus on tertiary care facilities. Both the hospitals offer a comprehensive range of healthcare services in specialties and super specialties, including cardiac sciences, neurosciences, orthopedics, renal sciences and mother and childcare.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Sangani Hospitals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)28.9 against a typical 48.9: cheaper than most peers (1st = cheapest).9th of 40
- Sales growth+975% against a typical +21.1% from a year earlier.1st of 34
- Profit growth+50% against a typical +13% from a year earlier.5th of 31
- Share price, 3 months+45.7% against a typical −10.9%.1st of 34
- Size₹ 82.3 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).28th of 36
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 3 Sep 2026 | Other business matters | To consider other business matters |
| 30 May 2026 | Other business matters | To consider and approve the standalone and consolidated Audited Financial results of the Company and to consider other business matters |
| 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 2 Sep 2025 | Other business matters | To consider other business matters |
| 30 May 2025 | Financial Results/Other business matters | SANGANI : 30-May-2025 : The Company has informed the Exchange that a Board meeting to be held on May 28, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2025, To consider and approve the financial results for the period ended March 31, 2025 and other business matters |
| 28 May 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 6 | 10 | 8 | 8 | 10 | 11 | 20 | 86 |
| Expenses | 4 | 8 | 6 | 6 | 8 | 10 | 19 | 80 |
| Operating Profit | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 7 |
| OPM % | 24% | 17% | 22% | 17% | 17% | 7% | 7% | 8% |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit before tax | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 6 |
| Tax % | 25% | 28% | 39% | 14% | 25% | 24% | 22% | 29% |
| Net Profit | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 3 |
| EPS in Rs | 0.86 | 0.62 | 0.75 | 1.2 | 1.24 | 0.65 | 0.73 | 1.44 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 90%
- TTM
- 405%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 24%
- TTM
- 15%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 13%
- TTM
- —
- 10 Years
- —
- 5 Years
- 9%
- 3 Years
- 8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Sangani Hospitals | ₹ 62.65 | ₹ 82 Cr. | 28.9x | 2x | 8% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 56.2x | 11.6x | — | 8.1% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 57.3x | 7.9x | — | 16.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 84.3x | 7.7x | — | 7.4% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 54.5x | 5.8x | — | 11.3% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 40.1x | 7.6x | — | 9.1% |
Management
- Rajeshkumar Natvarlal Sangani
- Executive Chairman of the Board
- Chandniben Ajaykumar Sangani
- Chief Financial Officer
- Gaurav Sureshbhai Patadia
- Compliance Officer, Company Secretary
- Ajaykumar Natavarlal Sangani
- Managing Director, Executive Director
- Kamalkumar Natavarlal Sangani
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.